S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
3 Magnificent Seven Stocks Outperforming the Rest
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
3 Magnificent Seven Stocks Outperforming the Rest
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
3 Magnificent Seven Stocks Outperforming the Rest
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
3 Magnificent Seven Stocks Outperforming the Rest
Closing prices for crude oil, gold and other commodities
NASDAQ:LPCN

Lipocine (LPCN) Stock Price, News & Analysis

$5.27
-0.17 (-3.13%)
(As of 04/19/2024 ET)
Today's Range
$5.26
$5.53
50-Day Range
$3.58
$6.51
52-Week Range
$2.31
$7.15
Volume
11,278 shs
Average Volume
152,690 shs
Market Capitalization
$28.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
LPCN stock logo

About Lipocine Stock (NASDAQ:LPCN)

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. The company's pipeline candidates also include TLANDO XR a candidate for oral TRT for once daily dosing, which has completed Phase 2b clinical study; LPCN 1148, an oral prodrug of bioidentical testosterone, being developed for the treatment of cirrhosis, currently under Phase 2 clinical studies; LPCN 1154, An oral neurosteroid, being developed for the treatment of postpartum depression, currently under Phase 2 studies; LPCN 2101, a NAS candidate, for women with epilepsy; and LPCN 2203 for essential tremor. It is also involved in the development of LPCN 1144, an oral prodrug of bioidentical testosterone for the treatment of pre-cirrhotic non-alcoholic steatohepatitis, which has completed Phase 2 testing; and LPCN 1107, an oral product candidate of 17-alpha-hydroxy progesterone caproate product, currently under Phase 3 studies for the prevention of recurrent preterm birth. The company was founded in 1997 and is headquartered in Salt Lake City, Utah.

LPCN Stock Price History

LPCN Stock News Headlines

Lipocine (NASDAQ:LPCN) Now Covered by StockNews.com
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
StockNews.com Begins Coverage on Lipocine (NASDAQ:LPCN)
LPCN Stock Earnings: Lipocine Beats EPS for Q4 2023
Lipocine GAAP EPS of -$3.14
Lipocine to Present at 36th Annual Roth Conference
Lipocine Signs TLANDO Franchise License Deal With Verity Pharma
See More Headlines
Receive LPCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/07/2024
Today
4/20/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LPCN
Employees
17
Year Founded
1997

Profitability

Net Income
$-16,350,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$-2,850,818.00
Book Value
$3.83 per share

Miscellaneous

Free Float
5,050,000
Market Cap
$28.02 million
Optionable
No Data
Beta
1.05

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Mahesh V. Patel Ph.D. (Age 67)
    Co-Founder, Interim Principal Financial Officer, Director, President & CEO
    Comp: $598.91k
  • Ms. Krista Fogarty (Age 56)
    Principal Accounting Officer & Corporate Controller
    Comp: $268.12k
  • Dr. Nachiappan Chidambaram Ph.D. (Age 54)
    Senior Vice President of Research & Development
    Comp: $311.17k
  • Mr. Logan Morse (Age 54)
    Vice President of Sales, Marketing & Operations
    Comp: $413.58k
  • Mr. Morgan R. Brown CPA (Age 56)
    M.B.A., Corporate Secretary
    Comp: $472.45k

LPCN Stock Analysis - Frequently Asked Questions

How have LPCN shares performed in 2024?

Lipocine's stock was trading at $2.79 at the beginning of 2024. Since then, LPCN stock has increased by 88.9% and is now trading at $5.27.
View the best growth stocks for 2024 here
.

When is Lipocine's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our LPCN earnings forecast
.

How were Lipocine's earnings last quarter?

Lipocine Inc. (NASDAQ:LPCN) released its earnings results on Thursday, March, 7th. The specialty pharmaceutical company reported ($0.42) EPS for the quarter, topping the consensus estimate of ($0.53) by $0.11. The specialty pharmaceutical company earned $0.22 million during the quarter.

When did Lipocine's stock split?

Shares of Lipocine reverse split before market open on Friday, May 12th 2023. The 1-17 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

What other stocks do shareholders of Lipocine own?
How do I buy shares of Lipocine?

Shares of LPCN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LPCN) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners